Preformulation and preliminary formulation studies of mesalazine gastro-resistant tablets
Mesalamine, 5-aminosalicylic acid or mesalazine is the standard therapy of inflammatory bowel disease. A small number of pharmaceutical dosage forms with mesalazine are on the market. The aim of this study was preformulation and preliminary formulation studies of oral gastro-resistant tablets conta...
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Amaltea Medical Publishing House
2020-12-01
|
| Series: | Romanian Journal of Pharmaceutical Practice |
| Subjects: | |
| Online Access: | https://farma.com.ro/articles/2020.4/RJPhP_2020_4_Art-05.pdf |